Multi‐Enzyme Nanoparticles as Efficient Pyroptosis and Immunogenic Cell Death Inducers for Cancer Immunotherapy
Advanced Science · 2024
DOI: 10.1002/advs.202408729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Hekai Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China. Hauptthemen laut MEDLINE: Pyroptosis, Immunotherapy, Immunogenic Cell Death, Nanoparticles. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Project of Shandong Second Medical University, Natural Science Foundation of Shandong Province, Dongying Natural Science Foundation.
Abstract (Originalsprache)
Immunotherapy represents a widely employed modality in clinical oncology, leveraging the activation of the human immune system to target and eradicate cancer cells and tumor tissues via endogenous immune mechanisms. However, its efficacy remains constrained by inadequate immune responses within “cold” tumor microenvironment (TME). In this study, a multifunctional nanoscale pyroptosis inducer with cascade enzymatic activity (IMZF), comprising superoxide dismutase (SOD), catalase (CAT), peroxidase (POD), and glutathione oxidase (GSHO x ), is dissociated within the acidic and glutathione‐rich TME. The vigorous enzymatic activity not only generates oxygen (O 2 ) to alleviate hypoxia and promote M2 to M1 macrophage polarization but also yields reactive oxygen species (ROS) and depletes glutathione (GSH) within the TME. Functioning as an immunogenic cell death (ICD) activator and pyroptosis inducer, IMZF synergistically triggers dendritic cell maturation and inflammatory lymphocyte infiltration via ICD‐associated pyroptosis, thereby reversing immune suppression within the TMEs. Consequently, it exerts inhibitory effects on both primary and distal tumors. This cascade enzymatic platform‐based pyroptosis inducer offers an intelligent strategy for effectively overcoming immune suppression within “cold” tumors, thereby providing a promising avenue for advanced immunotherapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China.
- Harway Pharma Co., Ltd., Dongying, 254753, China.
- State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, 116024, China.
ORCID-Profile: Wenda Zhong
Förderung
- Scientific Research Project of Shandong Second Medical University
- Natural Science Foundation of Shandong Province
- Dongying Natural Science Foundation
- Yellow River Delta industry-leading talents
Zitieren
APA
Yang, H., Xu, G., Li, F., Guo, G., Yan, P., Chen, Y., Chen, Y., Sun, W., Song, W., & Zhong, W. (2024). Multi‐Enzyme Nanoparticles as Efficient Pyroptosis and Immunogenic Cell Death Inducers for Cancer Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202408729
Vancouver
Yang H, Xu G, Li F, Guo G, Yan P, Chen Y, et al. Multi‐Enzyme Nanoparticles as Efficient Pyroptosis and Immunogenic Cell Death Inducers for Cancer Immunotherapy. Advanced Science. 2024. doi:10.1002/advs.202408729
BibTeX
@article{Yang2024,
author = {Yang, Hekai and Xu, Guangzhao and Li, Fahui and Guo, Guanhong and Yan, Ping and Chen, Yuxi and Chen, Yongkang and Sun, Wen and Song, Weiguo and Zhong, Wenda},
title = {Multi‐Enzyme Nanoparticles as Efficient Pyroptosis and Immunogenic Cell Death Inducers for Cancer Immunotherapy},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202408729}
}
EUVIMED